Healix Health, the UK’s only independent healthcare trust provider, has today announced the launch of its new Precision Cancer Service, developed in partnership with Further, a global healthcare solutions provider, as an extension of its existing cancer care pathway.
By combining advanced genomic testing with expert clinical support, the service can deliver significant cost savings for employers while improving survival rates and employee outcomes.
By embedding precision medicine into the cancer pathway, Healix Health is helping to ensure employees and their families receive the right treatment first time. Precision medicine has been shown to avoid up to 38% of serious misdiagnoses, reduce treatment costs by 35%, and improve survival rates.
This innovative approach supports employees throughout every stage of their cancer journey, helping to reduce time away from work, minimise unnecessary side effects, and boost overall wellbeing and morale. The launch reflects Healix’s commitment to delivering clinically excellent, compassionate and continuous care.
How the Precision Cancer Service works
The new Precision Cancer Service is offered for a fixed annual fee per principal member (including spouse and dependents) and available to employees diagnosed with stage 3 or 4 cancer, rare cancers, cancers of unknown primary and cancers that haven’t responded to first-line treatment.
The service is activated by the Healix clinical team, who coordinate access for eligible patients. Advanced genomic testing is then carried out by Further, with results reviewed by an international panel of precision medicine experts. These specialists develop a personalised treatment plan that incorporates relevant clinical trials and any hereditary considerations.
Patients receive their results in a consultation with a Further clinical case manager, who provides clear guidance, supports clinical trial enrolment where appropriate, and offers access to a dedicated genetics pathway for cancers with hereditary features.
Alongside this, a Healix Health nurse provides ongoing support throughout the cancer journey, ensuring consistent, patient-centred care for employees and their families, while also helping employers manage high-cost claims effectively.
Ian Talbot, CEO at Healix Health, said:
“Cancer touches every organisation. It’s no longer rare; it’s a reality for any modern workforce, with nearly a third of private healthcare claims costs now related to cancer. While advances in treatment have improved survival rates, they have also introduced new complexities, rising costs and greater expectations.
“This new service is going to make a big difference to the way employers tackle cancer. By combining advanced testing with expert nurse support, the service helps deliver better outcomes for employees, strong engagement and productivity for businesses, and sustainable cost control for employers, while providing compassionate, world-class care at every level.”
